by Maria Zannes | Jun 16, 2020 | Press Releases
Philanthropist was Devoted to Bringing Life-Saving Tests and Treatments to Those In Need JUNE 16, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biomedical company, today named its research laboratories in memoriam of Harvey Sandler, a businessman...
by Maria Zannes | Jun 10, 2020 | Press Releases
Trial results of automated test demonstrate non-invasive CyPath® Lung is highly accurate in finding lung cancer FAQ: Answers to Questions about Cypath® Lung JUNE 10, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced its...
by Maria Zannes | Oct 11, 2019 | Events, Press Releases
OCTOBER 11, 2019 (San Antonio, TX) bioAffinity Technologies, a privately-held biotech company, today announced that it has been accepted as a member of the American Cancer Society’s National Lung Cancer Roundtable (NLCRT), a collaborative whose membership is focused...
by Maria Zannes | Oct 2, 2019 | Press Releases
OCTOBER 2, 2019 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced the members of its Scientific and Medical Advisory (SMA) Board who will provide independent expert advice and counsel on the Company’s research and...
by Maria Zannes | Mar 12, 2019 | Press Releases
MARCH 12, 2019 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide independent expert advice and counsel on the Company’s research and development of...
by Maria Zannes | Mar 6, 2019 | Press Releases
MARCH 6, 2019 (San Antonio, TX) Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics for cancer, as one of 10 finalists for the second annual in Oncology. The Innovation...
